DK2274623T3 - Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension - Google Patents

Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension

Info

Publication number
DK2274623T3
DK2274623T3 DK09742310.7T DK09742310T DK2274623T3 DK 2274623 T3 DK2274623 T3 DK 2274623T3 DK 09742310 T DK09742310 T DK 09742310T DK 2274623 T3 DK2274623 T3 DK 2274623T3
Authority
DK
Denmark
Prior art keywords
arterial hypertension
pulmonary arterial
procedure
diagnosing pulmonary
paht
Prior art date
Application number
DK09742310.7T
Other languages
English (en)
Inventor
Luc Mouthon
Marc Humbert
Mathieu Tamby
Original Assignee
Assist Publ Hopitaux De Paris
Univ Paris Descartes
Univ Paris Sud 11
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris, Univ Paris Descartes, Univ Paris Sud 11 filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of DK2274623T3 publication Critical patent/DK2274623T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
DK09742310.7T 2008-04-11 2009-04-10 Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension DK2274623T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0852459A FR2930036B1 (fr) 2008-04-11 2008-04-11 Procede de diagnostic d'une hypertension arterielle pulmonaire.
PCT/FR2009/050661 WO2009136112A1 (fr) 2008-04-11 2009-04-10 Procede de diagnostic d'une hypertension arterielle pulmonaire

Publications (1)

Publication Number Publication Date
DK2274623T3 true DK2274623T3 (da) 2012-01-09

Family

ID=39876870

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09742310.7T DK2274623T3 (da) 2008-04-11 2009-04-10 Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension

Country Status (10)

Country Link
US (1) US8609356B2 (da)
EP (1) EP2274623B1 (da)
JP (1) JP5518836B2 (da)
AT (1) ATE528651T1 (da)
CA (1) CA2721049C (da)
DK (1) DK2274623T3 (da)
ES (1) ES2376459T3 (da)
FR (1) FR2930036B1 (da)
PT (1) PT2274623E (da)
WO (1) WO2009136112A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2964314B1 (fr) * 2010-09-02 2013-06-28 Assist Publ Hopitaux De Paris Score predictif du risque de survenue d'hypertension arterielle pulmonaire chez des patients atteints de sclerodermie systemique.
KR20140109956A (ko) * 2011-12-12 2014-09-16 아이시스 이노베이션 리미티드 테나신-c 및 류마티스 관절염에서의 이의 용도
WO2014067965A1 (en) * 2012-10-29 2014-05-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods of predicting or diagnosing a pulmonary arterial hypertension
WO2014089017A1 (en) * 2012-12-03 2014-06-12 Vascular Biosciences Methods for increasing the selective efficacy of gene therapy using car peptide and heparan-sulfate mediated macropinocytosis
JP6116938B2 (ja) * 2013-02-28 2017-04-19 学校法人順天堂 新規な肺高血圧症のマーカー

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880750A (en) * 1987-07-09 1989-11-14 Miragen, Inc. Individual-specific antibody identification methods
WO1999043308A2 (en) * 1998-02-27 1999-09-02 Marlene Rabinovitch Treating pulmonary hypertension through tenascin suppression and elastase inhibition
DE19939575C1 (de) * 1999-08-20 2001-08-02 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von Sjögren-Syndrom
JP3646159B2 (ja) * 2001-02-08 2005-05-11 国立大学法人三重大学 抗テネイシンｃモノクローナル抗体及び当該抗体を産生するハイブリドーマ
US6989276B2 (en) * 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
US7438908B2 (en) * 2002-02-26 2008-10-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anti-human tenascin monoclonal antibody
WO2005009366A2 (en) * 2003-07-24 2005-02-03 Cornell Research Foundation, Inc. Restoring vascular function
US20080026485A1 (en) * 2006-04-18 2008-01-31 Wolfgang Hueber Antibody profiling for determination of patient responsiveness
US20120295797A1 (en) * 2008-04-02 2012-11-22 Jones Peter L Methods for diagnosis and prognosis of pulmonary hypertension

Also Published As

Publication number Publication date
EP2274623A1 (fr) 2011-01-19
JP2011516876A (ja) 2011-05-26
ATE528651T1 (de) 2011-10-15
JP5518836B2 (ja) 2014-06-11
FR2930036B1 (fr) 2010-05-07
CA2721049C (fr) 2016-02-09
FR2930036A1 (fr) 2009-10-16
US20110033876A1 (en) 2011-02-10
CA2721049A1 (fr) 2009-11-12
WO2009136112A1 (fr) 2009-11-12
US8609356B2 (en) 2013-12-17
EP2274623B1 (fr) 2011-10-12
PT2274623E (pt) 2012-01-05
ES2376459T3 (es) 2012-03-14

Similar Documents

Publication Publication Date Title
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
DE602007003833D1 (de) Verbesserte vitamin-d-messung
HK1151958A1 (en) Optical sensor for determining the concentration of an analyte
DK2445394T3 (da) Fremgangsmåde og system til tilvejebringelse af både en estimeret sand middelblodglucoseværdi og estimeret glycosyleret hæmoglobin (HbA1C)-værdi ud fra strukturerede spot-målinger af blodglucose
WO2006113245A3 (en) Methods for measuring glycan levels of proteins
DK1904627T3 (da) Fremgangsmåde til fremstilling af prrs-virus og proteiner og diagnostiske testkits til detektion deraf
DK2126582T3 (da) Fremgangsmåde til påvisning af antistoffer fra kropsvæsker via en immunreaktion med glykoprotein 2 (gp2) fra zymogene granula af pankreas til differentialdiagnose af inflammatoriske tarmsygdomme og kronisk pankreatitis
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
DK2274623T3 (da) Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension
CY1122360T1 (el) Μεθοδος για τη διαγνωση της νοσου niemann-pick
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
DK2183599T3 (da) Højfølsomme immunoassays og kits til bestemmelse af peptider og proteiner af biologisk interesse
WO2010129354A3 (en) Compositions and methods for detecting predisposition to a substance use disorder
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
RU2013138721A (ru) Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови
WO2008073895A3 (en) Methods and devices for testing saliva
ATE474228T1 (de) Reagenz für hämoglobinabbau
WO2010009074A3 (en) Method for predicting and detecting tumor metastasis
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
WO2010097553A3 (fr) Procédé de diagnostic d'une vascularite